Adipocyte‐specific deletion of Mettl14 protects against diet‐induced obesity, NAFLD, and metabolic disease through increasing adipose β adrenergic signaling and lipolysis. Here, METTL14 is linked to obesity due to melanocortin 4 receptor deficiency.